{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:03:05Z","timestamp":1770469385665,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1994,10,1]],"date-time":"1994-10-01T00:00:00Z","timestamp":780969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Biology"],"published-print":{"date-parts":[[1994,10]]},"DOI":"10.1016\/s0960-9822(00)00195-0","type":"journal-article","created":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T18:22:43Z","timestamp":1090434163000},"page":"865-875","source":"Crossref","is-referenced-by-count":228,"title":["Allosteric activation of latent p53 tetramers"],"prefix":"10.1016","volume":"4","author":[{"given":"Ted R.","family":"Hupp","sequence":"first","affiliation":[]},{"given":"David P.","family":"Lane","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0960-9822(00)00195-0_BIB1","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1128\/MCB.4.9.1689","article-title":"UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells","volume":"4","author":"Maltzman","year":"1984","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB2","first-page":"6304","article-title":"Participation of p53 protein in the cellular response to DNA damage","volume":"51","author":"Kastan","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0092-8674(93)90496-D","article-title":"Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes?","volume":"75","author":"Lu","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB4","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1073\/pnas.89.16.7491","article-title":"Wild type p53 is a cell cycle checkpoint determinant following irradiation","volume":"89","author":"Kuerbitz","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB5","first-page":"203","article-title":"High levels of p53 protein in UV irradiated human skin","volume":"8","author":"Hall","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB6","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1128\/MCB.13.7.4242","article-title":"Induction of cellular p53 activity by DNA-damaging agents and growth arrest","volume":"13","author":"Zhan","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/352345a0","article-title":"Wild-type p53 induces apoptosis if myeloid leukaemic cells that is inhibited by interleukin-6","volume":"352","author":"Yonish-Rouach","year":"1991","journal-title":"Nature"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/362849a0","article-title":"Thymocyte apoptosis induced by p53-dependent and independent pathways","volume":"362","author":"Clarke","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/362847a0","article-title":"p53 is required for radiation-induced apoptosis in mouse thymocytes","volume":"362","author":"Lowe","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB10","first-page":"614","article-title":"The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice","volume":"54","author":"Merritt","year":"1994","journal-title":"Cancer Research"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB11","first-page":"1169","article-title":"WAF1\/CIP1 is induced in p53-mediated G1 arrest and apoptosis","volume":"54","author":"Barak","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB12","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0092-8674(92)90644-R","article-title":"The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation","volume":"69","author":"Momand","year":"1992","journal-title":"Cell"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1,a potential mediator of p53 tumor suppression","volume":"75","author":"El-Deiry","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB14","first-page":"1169","article-title":"WAF1\/CIP1 is induced in p53-mediated G1 arrest and apoptosis","volume":"54","author":"El-Deiry","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0092-8674(94)90379-4","article-title":"p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest","volume":"76","author":"Dulic","year":"1994","journal-title":"Cell"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/366701a0","article-title":"p21 is a universal inhibitor of cyclin kinases","volume":"366","author":"Xiong","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 cdk-Interacting Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/369574a0","article-title":"The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA","volume":"369","author":"Waga","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1242\/jcs.105.3.607","article-title":"Regulation of p53 protein expression in human breast cancer cell lines","volume":"105","author":"Vojtesek","year":"1993","journal-title":"J Cell Sci"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB20","first-page":"893","article-title":"Genetic and immunochemical analysis of mutant p53 in human breast cancer","volume":"5","author":"Bartek","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB21","first-page":"1699","article-title":"Abberant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies","volume":"6","author":"Bartek","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0140-6736(92)92354-I","article-title":"Abnormal expression of wild type p53 protein in normal cells of a cancer family patient","volume":"340","author":"Barnes","year":"1992","journal-title":"The Lancet"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB23","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1073\/pnas.91.6.1998","article-title":"Sequence-specific transcriptional activation is essential for growth suppression by p53","volume":"91","author":"Pietenpol","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/nar\/20.7.1539","article-title":"Mammalian p53 can function as a transcription factor in yeast","volume":"20","author":"Scharer","year":"1992","journal-title":"Nucl Acids Res"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB25","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1128\/MCB.12.6.2866","article-title":"A transcriptionally active DNA-binding site for human p53 protein complexes","volume":"12","author":"Funk","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/362857a0","article-title":"Oncoprotein MDM2 conceals activation domain of tumour suppressor p53","volume":"362","author":"Oliner","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB27","unstructured":"SM Picksley, B Vojtesek, A Sparks, DP Lane, Immunochemical analysis of the interaction of p53 with MDM2; fine mapping of the MDM2 binding site on p53 using synthetic peptides, Oncogene 9 2523-2529."},{"key":"10.1016\/S0960-9822(00)00195-0_BIB28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.8023157","article-title":"Crystal structure of p53 tumor suppressor-DNA complex: detailed view of the mutation hotspots","volume":"265","author":"Cho","year":"1994","journal-title":"Science"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB29","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/j.1460-2075.1990.tb08279.x","article-title":"Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form","volume":"9","author":"Gannon","year":"1990","journal-title":"EMBO J"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0022-2836(92)90386-X","article-title":"Mutant conformation of p53: precise epitope mapping using a filamentous phage epitope library","volume":"225","author":"Stephen","year":"1992","journal-title":"J Mol Biol"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.8023159","article-title":"High resolution structure of the oligomerization domain of p53 by multidimensional NMR","volume":"265","author":"Clore","year":"1994","journal-title":"Science"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB32","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/MCB.6.5.1379","article-title":"Characterization of the human p53 gene","volume":"6","author":"Lamb","year":"1986","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0092-8674(92)90562-Q","article-title":"Regulation of the Specific DNA Binding Function of p53","volume":"71","author":"Hupp","year":"1992","journal-title":"Cell"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB34","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1093\/nar\/20.21.5565","article-title":"Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53","volume":"20","author":"Milne","year":"1992","journal-title":"Nucl Acids Res"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB35","first-page":"1635","article-title":"Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells","volume":"7","author":"Ullrich","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB36","unstructured":"TR Hupp, DP Lane, Regulation of the cryptic sequence-specific DNA binding function of p53 by protein kinases, Cold Spring Harb Symp Quant Biol in press (96063088)."},{"key":"10.1016\/S0960-9822(00)00195-0_BIB37","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1128\/MCB.14.3.1698","article-title":"Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells","volume":"14","author":"Kulesz-Martin","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1146\/annurev.bi.61.070192.005201","article-title":"Transcription factors: structural families and principles of DNA recognition","volume":"61","author":"Pabo","year":"1992","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB39","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/j.1460-2075.1993.tb05893.x","article-title":"p53-catalyzed annealing of complementary single-stranded nucleic acids","volume":"12","author":"Oberosler","year":"1993","journal-title":"EMBO J"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1073\/pnas.91.1.413","article-title":"p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer","volume":"91","author":"Bakalkin","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mc.2940050204","article-title":"Formation of stable p53 homotetramers and multiples of tetramers","volume":"5","author":"Stenger","year":"1992","journal-title":"Mol Carcinog"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB42","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1073\/pnas.90.8.3319","article-title":"The p53 protein is an unusually shaped tetramer that binds directly to DNA","volume":"90","author":"Friedman","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB43","first-page":"1361","article-title":"Phosphorylation of the p53 tumor-suppressor protein at three N terminal sites by a novel casein kinase 1-like enzyme","volume":"7","author":"Milne","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB44","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1002\/j.1460-2075.1990.tb07524.x","article-title":"The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II","volume":"9","author":"Meek","year":"1990","journal-title":"EMBO J"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB45","first-page":"877","article-title":"Association of casein kinase II with immunopurified p53","volume":"6","author":"Herrmann","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB46","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1128\/MCB.12.11.5041","article-title":"Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53","volume":"12","author":"Lees-Miller","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB47","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.87.12.4766","article-title":"Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2","volume":"87","author":"Bischoff","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB48","doi-asserted-by":"crossref","first-page":"11627","DOI":"10.1073\/pnas.89.23.11627","article-title":"Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein","volume":"89","author":"Baudier","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB49","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.1016\/S0021-9258(17)37101-6","article-title":"Phosphorylation of the tumour suppressor protein p53 by mitogen-activated protein kinases","volume":"269","author":"Milne","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB50","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1101\/gad.7.12b.2575","article-title":"p53 domains: identification and characterization of two autonomous DNA-binding regions","volume":"7","author":"Wang","year":"1993","journal-title":"Genes Dev"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB51","series-title":"Fundamentals of Enzymology","author":"Price","year":"1989"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ng0492-45","article-title":"Definition of a consensus binding site for p53","volume":"1","author":"El-Deiry","year":"1992","journal-title":"Nature Genet"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB53","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1101\/gad.6.10.1886","article-title":"Site-specific DNA binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53","volume":"6","author":"Bargonetti","year":"1992","journal-title":"Genes Dev"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/hyb.1986.5.199","article-title":"Enhanced binding activity observed between anti-carcinoembryonic monoclonal antibodies","volume":"5","author":"Wellerson","year":"1985","journal-title":"Hybridoma"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0968-0004(84)90033-1","article-title":"Cyclic complexes and high avidity antibodies","volume":"9","author":"Thompson","year":"1984","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB56","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/nar\/21.14.3167","article-title":"Activation of the Cryptic DNA Binding Function of Mutant Forms of p53","volume":"21","author":"Hupp","year":"1993","journal-title":"Nucl Acids Res"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB57","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1002\/j.1460-2075.1993.tb06199.x","article-title":"Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants","volume":"12","author":"Halazonetis","year":"1993","journal-title":"EMBO J"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0022-2836(63)80091-1","article-title":"Allosteric proteins and cellular control systems","volume":"6","author":"Monod","year":"1963","journal-title":"J Mol Biol"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB59","series-title":"Antibodies: A laboratory manual","author":"Harlow","year":"1988"},{"key":"10.1016\/S0960-9822(00)00195-0_BIB60","first-page":"945","article-title":"Structural aspects of the p53 protein in relation to gene evolution","volume":"5","author":"Soussi","year":"1990","journal-title":"Oncogene"}],"container-title":["Current Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960982200001950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960982200001950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T10:20:26Z","timestamp":1624530026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960982200001950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1994,10]]}},"alternative-id":["S0960982200001950"],"URL":"https:\/\/doi.org\/10.1016\/s0960-9822(00)00195-0","relation":{},"ISSN":["0960-9822"],"issn-type":[{"value":"0960-9822","type":"print"}],"subject":[],"published":{"date-parts":[[1994,10]]}}}